Inovio Pharmaceuticals Inc (INO.O) is focused on launching the global late-stage trial of its COVID-19 vaccine candidate next month, top boss Joseph Kim said in a call on Monday, with the drug developer expecting data in the first half of next year.
A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvicis focused on launching the global late-stage trial of its COVID-19 vaccine candidate next month, top boss Joseph Kim said in a call on Monday, with the drug developer expecting data in the first half of next year.
The FDA's decision was followed by the U.S. government pulling funding for the late-stage study, citing the fast-moving environment of vaccine development. "We were initially focusing on Latin America and Asia Pacific, but looking at the rapidly changing vaccination rates and the virus epidemiology, we are including regions in Africa," a company executive said during the post-earnings call.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
COVID-19 live updates: Protests against mandated COVID-19 vaccines pop up across USThe World Health Organization issued a warning about online scams involving a phony COVID-19 lottery. LATEST UPDATES:
Consulte Mais informação »
COVID-19 live updates: 'This is not your grandfather's COVID,' pediatrician warns10 children were among the 78 new COVID patients admitted to Baptist Health in Jacksonville, Florida, on Sunday, the hospital says. The hospital has 584 COVID patients as of Monday. 21 of those patients are children, including six kids in intensive care.
Consulte Mais informação »
August EU Travel Restrictions, Covid-19 Test Requirements, Quarantine By CountryThe country-by-country picture of travel restrictions across the EU (and U.K.) for August–details on Covid-19 test and quarantine requirements, as well as green passes and EU Digital Covid Certificates.
Consulte Mais informação »